SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, ...

San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming ...

(RTTNews) - Hinge Health, Inc. (HNGE) on Wednesday announced that its board of directors has authorized a $250 million share repurchase program. "During the first three quarters of 2025, we generated ...

Detailed price information for Hinge Health Inc Cl A (HNGE-N) from The Globe and Mail including charting and trades.

A 12-week, 177-participant trial of Hinge Health’s at-home digital program for chronic pain relief significantly reduced users’ lower back pain, disability and interest in surgery. The study, led by ...

When digital musculoskeletal company Hinge Health launched about a decade ago, it primarily targeted employers directly. However, in recent years, it has expanded its health plan partnerships and is ...

Hinge Health Inc (HNGE) reports strong financial performance with a 46% revenue increase, while navigating competitive pressures and strategic investments.

Hinge Health (NYSE:HNGE) delivers AI-driven digital musculoskeletal care, showing revenue growth and institutional activity within the NYSE Composite sector today.

Combined with Hinge Health’s AI-powered exercise therapy program, HingeSelect adds access to high-quality in-person providers for members at up to 50% below PPO rates Hinge Health, Inc. (NYSE:HNGE), ...

Detailed price information for Hinge Health Inc Cl A (HNGE-N) from The Globe and Mail including charting and trades.

SAN FRANCISCO--(BUSINESS WIRE)-- Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today’s fragmented healthcare system leaves many ...